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Abstract
The high rate of glucose utilization by cancer cells has been well
characterized. Recent data suggest that when normal mammary
epithelial cells are cultured under nonadherent conditions, glucose
consumption decreases, ATP levels fall, and concentrations of
reactive oxygen species rise. The rise in reactive oxygen species
causes death of nonadherent cells, which can be suppressed with
antioxidants. Nonadherent ErbB2-transformed mammary epithelial
cells maintain glucose transport and antioxidant production;
however, antioxidants appear to enhance anchorage-independent
growth. These findings integrate aspects of glucose metabolism,
anoikis suppression and antioxidant production in tumor cell biology
and suggest that antioxidant therapy could stimulate tumor survival.
Reactive oxygen species (ROS) appear to play both positive
and negative roles in cancer cells [1,2]. The major source of
ROS is electron leakage from the mitochondrial electron
transport chain, which then react with molecular oxygen
forming ROS [2]. A number of oncogenes are known to
increase ROS that can promote genetic instability and tumor
aggressiveness [3-5]. Conversely, high levels of ROS are
known to kill cancer cells [6]. Cancer cells that successfully
manage levels of ROS could therefore gain a selective
advantage to expand a tumor.
Anoikis refers to cell death that occurs following detachment
of a cell from its native extracellular matrix [7]. A number of
mechanisms that tumor cells use to bypass anoikis have been
described [8], and this bypass must be accomplished in
order for tumor cells to survive when proliferating and
invading neighboring tissue. A recent article from the
laboratory of Joan Brugge demonstrates a role for ROS and
glucose metabolism in the context of mammary epithelial cells
detached from the matrix [9].
Schafer and colleagues demonstrate a decrease in the
amount of ATP in MCF10A mammary epithelial cells when
they are cultured under nonadherent conditions as opposed
to adherent conditions [9]. The decrease in ATP levels is
concomitant with a decrease in glucose consumption and an
increase in ROS, which the authors suggest is due to a
decrease in the flux of glucose through the pentose
phosphate pathway. The pentose phosphate pathway is
important because it produces nicotinamide adenine
dinucleotide phosphate (NADPH), which is needed to reduce
glutathione, which in turn eliminates ROS. ATP levels can be
rescued in detached mammary epithelial cells by expressing
the ErbB2 oncogene or by reducing ROS with supplemental
antioxidants (which restores the catabolism of fatty acids as
an energy source in the absence of glucose). Evaluation of
MCF10A 3D acinar structures reveals that cells within the
luminal space, not in contact with the extracellular matrix,
have higher levels of ROS. Treatment of acinar structures
with antioxidants prevents normal lumen clearing. Finally, it
was demonstrated that colony formation by several cell lines
that grow poorly in soft agar could be stimulated by treatment
with antioxidants.
The authors conclude that detachment from the extracellular
matrix causes normal cells to undergo cell death due to
oxidative stress caused by reduced glucose metabolism, which
can be suppressed by antioxidants. Further, transformed cells
are better able to adapt to the nonadherent state due to their
altered metabolism, and antioxidants aid in the survival and
proliferation of transformed and pre-neoplastic cells [9].
Schafer and colleagues demonstrated mechanisms by which
a transformed cell adapts its metabolism in order to survive in
an extracellular environment where an untransformed cell
would struggle to survive [9]. The link between glucose
metabolism, antioxidant production and survival of detached
cells is a remarkable discovery; however, a number of
additional, unresolved questions come to mind.
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The use of detached cells in culture makes for a flexible,
controllable model to study metabolic changes that occur in
nonadherent cells. The relevance of this model to mammary
duct lumen formation and mammary tumor cell detachment in
vivo, however, must also be addressed. It would be
interesting to know whether antioxidants would increase
tumor cell survival and colonization of the lung or bone using
intravenous or intracardiac xenograft mouse models [10], and
whether antioxidants would stimulate the growth of primary
tumors and/or metastatic tumors as observed in soft agar
colony assays [9]. Of course, the ultimate question is the
relevance to human breast cancer, which could be addressed
by a large-scale clinical trial of antioxidants. Comprehensive
epidemiologic data have been inconclusive regarding the
effect of antioxidants on breast cancer progression [11], but
many of these studies have focused upon ancillary or
palliative aspects of treatment.
Schafer and colleagues focused upon glucose flux into the
pentose phosphate pathway supporting NADPH production
and glutathione reduction [9], but they also reported that
malate (another source for NADPH production) could rescue
detached cells from oxidative stress. In glioblastoma cells,
glutamine flux through the tricarboxylic acid cycle to form
malate and to reduce NADPH is as great as glucose flux
through the pentose phosphate pathway [12]. These two
mechanisms of NADPH production indicate the importance
of this reducing agent; however, its eventual use is unclear.
Schafer and colleagues suggest NADPH is used to reduce
glutathione, to combat oxidative stress and to support the
oxidation of fatty acids in detached cells [9]. Conversely,
DeBerardinis and colleagues suggest that the reducing
power of NADPH is used to drive fatty acid synthesis [12].
NADPH is probably used by a cancer cell to reduce
glutathione and to combat oxidative stress as well as to drive
the synthesis of fatty acids and nucleotides depending on the
oxidative and/or bioenergetic stress that cell is experiencing.
The culture conditions used by Schafer and colleagues have
high concentrations of glutamine, but evaluation of glutamine
usage by MCF10A cells was not reported.
Other questions raised by the findings of Schafer and
colleagues’ research [9] include the following. By what
molecular mechanism do ROS impair oxidation of fatty acids?
Does pyruvate rescue of ATP production in detached cells
affect glutathione reduction? For how long will antioxidants
rescue detached cells? Does altering the extracellular
environment of a cancer cell have the same effect on
metabolism and oxidative stress as detaching cells? Which
attributes of apoptosis and autophagy are utilized during
anoikis? What signaling pathways downstream of the
epidermal growth factor receptor, phosphoinositide 3 kinase,
and Akt are involved to modulate ATP, reducing glutathione
and ROS levels? Resolution of these questions is likely to
provide new insights into metabolism and tumor progression.
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